#University of California, San Francisco

New data show that immune-based therapies may activate cancer-fighting T cells in lymph nodes near tumors.

For every dollar spent on its anti-smoking program, California has seen a $231 return.

A Q&A with University of California, San Francisco’s Karla Kerlikowske, MD, about cancer, obesity, breast density, inflammation and more

Damon Runyon and UCSF researchers aim to design CAR T cells with longer-lasting, more powerful anti-tumor immunity. Here’s how.

Balyn Zaro, PhD, studies genetic differences in the innate immune system and how they can impact the effectiveness of the meds we take.

On the operating table and inside the lab of a rising star in cancer neurosurgery.

Bitopic inhibitors may lay the foundation for a new approach to disease treatments, say UCSF researchers.

Predictive model allows researchers to encode commands for cells to carry out, such as ”Knock those tumor cells out, and keep at it.”

UCSF study sheds light on the reasons behind sex differences in cancer-associated myocarditis, an inflammation of the heart muscle.

University of California San Francisco hosted First Lady Jill Biden to speak about the Cancer Moonshot and breast cancer research.

Tumor immune microenvironments may provide clues to future therapies, say UCSF-led researchers.

Promising research shows that marking the mutated KRAS protein of cancer cells can signal the immune system to destroy that cancer.

Overturning Roe v. Wade may lead to compromises in cancer care and potential loss of life, according to UCSF perspective article.

The study of 273 cancer survivors found that over 50% experienced significant hearing loss and more than 35% reported tinnitus.

A global team studies the underlying forces that turn cells cancerous—and hopes to learn ways to stop cancer before it even starts.

A look at the scientists behind David Julius’s Nobel Prize for discoveries regarding the proteins that help us sense temperature and pain.